Last month the PALLAS trial revealed adverse cardiovascular risks in taking dronedarone (Multaq) for irregular heart beat. Now the European Society of Cardiology is suggesting its use be limited.

In addition to being costly, hospital intensive care units are constrictive for patients. Hoping to remedy that, one medical facility is testing the notion of a virtual intensive care unit where patients are free of wires and beeping machines.

Drug maker Pfizer is contemplating an over-the-counter version of its cholesterol drug Lipitor, The Wall Street Journal has reported, citing sources familiar with the effort.

Recreational activities such as golfing, hiking and swimming might do more than provide for a fun family weekend. They also appear to cut your risk of peripheral arterial disease, the narrowing of leg arteries.

Just recently heart pacemakers went wireless. Now there is potential to take them even a step further. In the future they could be light-controlled.

An irregular heart beat could be caused by a wide range of factors -- from scarring after a heart attack to diabetes and high blood pressure. New research also suggests a genetic link.

After suffering a life-threatening brain hemorrhage, many patients are very traumatized and fear recurrent hemorrhages, though the actual risk is very low.

Clot busting drugs reduce stroke disability, yet patients often don't receive the treatment. It appears that graduating neurology residents are becoming more comfortable with using the drug.

Depression is common among the elderly with many electing to take antidepressants. The new generation of antidepressants may be overly risky for older patients.